These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9431478)

  • 1. Treatment of congestive heart failure in the elderly: emphasis on renal functional changes and impact of therapy.
    Chau WL; Burnett JC
    Coron Artery Dis; 1997; 8(8-9):505-9. PubMed ID: 9431478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure.
    Cody RJ; Torre S; Clark M; Pondolfino K
    Arch Intern Med; 1989 May; 149(5):1023-8. PubMed ID: 2655542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure in the elderly.
    Tighe D; Brest AN
    Cardiovasc Clin; 1992; 22(2):127-38. PubMed ID: 1586914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current pharmacotherapy of heart insufficiency in old age].
    Bertel O; Marx B; Nägeli B
    Ther Umsch; 1989 Jan; 46(1):15-21. PubMed ID: 2922690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
    Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in renal function in experimental congestive heart failure.
    Awazu M; Ichikawa I
    Semin Nephrol; 1994 Sep; 14(5):401-11. PubMed ID: 7997647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function as a predictor of prognosis in chronic heart failure.
    Hillege H; Van Gilst W; de Zeeuw D; van Veldhuisen DJ
    Heart Fail Monit; 2002; 2(3):78-84. PubMed ID: 12634888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of congestive heart failure: neuroendocrine approach.
    Shmuely H; Sclarovsky S; Rosenfeld JB
    Isr J Med Sci; 1993 Jan; 29(1):6-10. PubMed ID: 8454456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
    Solter P; Sisson D; Thomas W; Goetze L
    J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory and adaptive mechanisms in congestive heart failure.
    Kiowski W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S3-8. PubMed ID: 2480483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X; Saini HK; Wang J; Gupta SK; Goyal RK; Dhalla NS
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):717-32. PubMed ID: 16076281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium and water retention in heart failure: pathogenesis and treatment.
    Martin PY; Schrier RW
    Kidney Int Suppl; 1997 Jun; 59():S57-61. PubMed ID: 9185106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M; Tocci G; Pagannone E
    Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.